TIDMCOS

RNS Number : 3580I

Collagen Solutions PLC

19 June 2017

Collagen Solutions Plc

(the "Company" or the "Group")

Notice of Results

Analyst briefing

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces they will issue their preliminary results for the year ending 31 March 2017 on Tuesday, 11 July 2017.

A briefing for analysts will take place at the offices of Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Tuesday, 11 July 2017.

If you would like to register to attend or require further information, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com.

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic, an osteochondral scaffold for repairing cartilage defects in the knee. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For further information, please contact:

 
 Collagen Solutions Plc                                             Contact via Walbrook 
 Jamal Rushdy, Chief Executive 
  Officer 
 Gill Black, Chief Financial 
  Officer 
 
 Cenkos Securities plc (Nominated                                     Tel: 0207 397 8900 
  Adviser and Broker) 
  Stephen Keys 
  Steve Cox 
 
 Walbrook PR                           Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Anna Dunphy                                                          Mob: 07876 741 001 
 Mike Wort                                                            Mob: 07900 608 002

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORSFFFEMFWSELM

(END) Dow Jones Newswires

June 19, 2017 02:00 ET (06:00 GMT)

Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Collagen Solutions Charts.
Collagen Solutions (LSE:COS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Collagen Solutions Charts.